Reliability of resting-state electrophysiology in fragile X syndrome

Objective: Fragile X Syndrome (FXS) is the leading monogenic cause of intellectual disability and autism spectrum disorder. Currently, there are no established biomarkers for predicting and monitoring drug effects in FXS, and no approved therapies are available. Previous studies have shown electroph...

詳細記述

書誌詳細
主要な著者: Rui Liu, Ernest V. Pedapati, Lauren M. Schmitt, Rebecca C. Shaffer, Elizabeth G. Smith, Kelli C. Dominick, Lisa A. DeStefano, Grace Westerkamp, Paul Horn, John A. Sweeney, Craig A. Erickson
フォーマット: 論文
言語:English
出版事項: Elsevier 2023-12-01
シリーズ:Biomarkers in Neuropsychiatry
主題:
オンライン・アクセス:http://www.sciencedirect.com/science/article/pii/S2666144623000102